Cholesterol-lowering drugs, led by the “statin” group, are among the most common treatments in cardiology and family medicine clinics around the world. It is not only used to improve test numbers, but also to prevent complications that could change a patient’s life in moments, such as heart attacks and strokes.
Despite these benefits, cholesterol medications are still surrounded by a lot of concern. Some patients fear muscle pain, others stop when liver enzymes may rise, while many hesitate to start treatment at all because of experiences they heard from relatives or friends.
Read also
list of 4 itemsend of list
But doctors confirm that the problem does not lie in the fear itself, but rather in the fact that this fear turns into an individual decision to stop the medication without medical advice.
In many cases, the risk of abandoning treatment is much higher than the risk of possible side effects, especially for patients with heart disease, diabetes, smokers, and those with a family history of early clots.
The stroke does not happen suddenly
Dr. Alia Abu Suleiman, a family medicine specialist and fellow of the British Royal College, says that cholesterol medications represent a cornerstone in the prevention and treatment of arterial diseases, especially in patients who are more susceptible to clots.
She explains that the role of these medications is not limited to reducing the level of harmful cholesterol in the blood, but extends deeper; It helps stabilize fatty deposits within the walls of the arteries, and reduces the possibility of their rupture, which is one of the most important causes that lead to sudden heart or strokes.
A stroke, as Dr. Alia explains, does not often occur in a vacuum. A person may live for years with 50 or 60% narrowing in one of the arteries without feeling clear symptoms. He goes to work, goes about his life, and perhaps feels reassured because he does not feel pain. But the real danger begins when one of the fatty deposits inside the artery ruptures, forming a clot that suddenly blocks it within minutes.
This is why she warns against stopping treatment without consulting a doctor, especially for those who have previously suffered a heart attack, had stents installed, or undergone heart surgery, because the goal here is not to reduce a number on the analysis sheet, but rather to prevent the recurrence of an incident that may be more serious.
Food is not the only one to blame
Many people associate high cholesterol with excessive fat intake alone, but the medical picture is more complex. According to Dr. Alia, there are patients who have high cholesterol even though they do not eat large amounts of fat, because the problem may be essentially hereditary, as the liver automatically produces high amounts of cholesterol.
Here, she points out the importance of analyzing the fatty protein known as Lipoprotein (A), especially for people who have a family history of early heart and arterial diseases. This analysis may reveal a genetic risk factor that is not always apparent through traditional lipid analysis alone.
It is increasingly important to pay attention to cholesterol in diabetics, because diabetes not only raises blood sugar levels, but also creates a chronic inflammatory environment within the lining of the arteries, making them more susceptible to fat deposition and the development of atherosclerosis.
In addition to this, smoking, which Dr. Alia describes as a silent and elusive risk factor; Many smokers believe that they are fine as long as they do not feel discomfort or pain, while inflammation and damage to the walls of blood vessels continue quietly for years.
How low should cholesterol be?
There is no one number that works for all people. The therapeutic goal varies from one person to another depending on age, medical history, and the presence of diabetes, high blood pressure, smoking, or previous heart disease.
In general, it is recommended that total cholesterol in people at low risk be less than 200 mg/dL. As for patients who have previously had heart attacks, had stents installed, or have proven coronary artery disease, treatment usually aims to reduce harmful LDL cholesterol to lower levels, which may be less than 70 mg/dL, and the doctor may recommend lower levels than that for some higher-risk groups.
Recent recommendations indicate that risk assessment no longer depends on the cholesterol number alone, but rather on the complete picture of the patient: Does he have diabetes? Does he smoke? Does he have a family history? Have you ever had a stroke? Are there signs of atherosclerosis in imaging tests?
Liver enzymes…when should we worry?
One of the most common concerns patients have is the effect of cholesterol medications on the liver. However, Dr. Alia explains that elevated liver enzymes may occur in a limited percentage of patients, but it is often temporary or subject to follow-up, and does not automatically mean that treatment must be stopped.
She says that the doctor may request tests before starting treatment or during follow-up when necessary, and he may merely monitor, adjust the dose, or change the type of medication if the situation requires. The most dangerous decision is for the patient to stop the medication himself as soon as he hears general information about “the harm of statins to the liver.”
The medical rule here is based on balancing benefit and risk. In a patient who has previously suffered a stroke or has multiple risk factors, the benefit of continuing treatment may be greater than the possibility of a side effect that can be monitored and dealt with.
The importance of early screening
Dr. Alia believes that the most common mistake is to wait for symptoms before testing, because high cholesterol and atherosclerosis may develop silently for a long time.
Basic tests include a complete lipid profile, which measures total cholesterol, bad LDL cholesterol, good HDL cholesterol, and triglycerides.
In some cases, the doctor may request additional tests, such as CRP associated with inflammation, a Lipoprotein (a) analysis, a CT scan of the coronary arteries, or a Doppler examination of the neck arteries, depending on the degree of risk.
Conducting these tests does not mean that every person needs medication, but rather it means that the treatment decision must be based on clear knowledge, not on guesswork or false reassurance.
Muscle pain does not mean the end of treatment
For his part, Dr. Mustafa Adous, a general practitioner at a medical center in Qatar, says that muscle pain is one of the most common complaints that patients associate with statin medications. These symptoms may appear in the form of pain, tightness, or muscle weakness, especially in the elderly or those who use multiple medications.
He explains that some types of statins may affect energy production pathways within muscle cells in a group of patients, which explains the appearance of complaints in some of them. But this does not mean that every muscle pain in a patient taking a statin is caused by the drug, nor does it mean that the treatment is over.
In turn, Dr. Alia confirms that the correct approach begins with informing the doctor, not stopping the medication. The doctor may reduce the dose, change the type of statin, try a different dosing regimen, or look for other causes of pain such as vitamin D deficiency, thyroid disorder, or drug interactions.
In some cases, the doctor may request a CK or CPK test to evaluate muscle involvement, especially if the pain is severe, recurrent, or accompanied by obvious weakness.
Dr. Adous points out that some doctors may use the CoQ10 supplement in selected cases, with the aim of improving treatment tolerance and reducing muscle complaints, but this must be under medical supervision, not as a substitute for treatment or an individual decision by the patient.
Treatment does not begin with medication alone
In turn, Dr. Mohamed Salah, a pharmacist in a private hospital in Qatar, explains that cholesterol is a necessary substance for the body, involved in building cells and producing some hormones, but the problem begins when its levels rise in a way that increases the risk of fat deposition inside the arteries.
He emphasizes that treatment does not always start from the medicine box, but rather from the lifestyle. Quitting smoking, losing weight when needed, reducing saturated and trans fats, increasing fiber, and engaging in regular physical activity are all essential steps to improving blood fats and vascular health.
Exercise not only helps lower harmful cholesterol, but also contributes to raising beneficial cholesterol and improving the body’s efficiency in dealing with excess fat. But when these measures are not enough, or the patient is high-risk, medication becomes an essential part of the prevention plan.
Dr. Mohamed Salah stresses that choosing the appropriate treatment is not random, but rather depends on the doctor’s assessment of risk factors, test results, medical history, and the patient’s tolerance for the medication.
How does the patient avoid risks?
The American Heart Association and other heart health medical societies recommend that cholesterol medications be part of a comprehensive plan, not a separate lifestyle treatment.
This plan is based on adhering to the prescribed medication, not stopping it or adjusting its dosage without consulting a doctor, periodically monitoring lipid levels, and paying attention to any severe muscle symptoms or signs that may indicate a liver problem, such as yellowing of the eyes, dark urine, or upper abdominal pain.
The plan also includes maintaining a healthy weight, engaging in regular physical activity, stopping smoking, and following a balanced diet rich in vegetables, whole grains, legumes, nuts, and fish, while reducing fried foods, processed meats, and saturated fats.
